Changes in lipids and lipoproteins after selective LDL apheresis (7-year experience)

Cholesterol

Volumn 2012, Issue , 2012, Pages

  Kolovou, Genovefa ^a   Hatzigeorgiou, Georgios ^a   Mihas, Constantinos ^b   Gontoras, Nikos ^a   Litras, Panagiotis ^a   Devekousos, Dimitris ^a   Kontodima, Panagiota ^a   Sorontila, Constantina ^a   Bilianou, Helen ^c   Mavrogeni, Sophie ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b Hospital General G Papanikolaou   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; COLESEVELAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRATE; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MALE; PRIORITY JOURNAL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84858249906     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2012/976578     Document Type: Article

References (26)

1. Austin M. A., Hutter C. M., Zimmern R. L., Humpries S. E., Familial hypercholesterolemia and coronary heart disease: a HuGE association review American Journal of Epidemiology 2004 160 5 421 429 (Pubitemid 39166974)
2. Emery J., Barlow-Stewart K., Metcalfe S. A., Sullivan D., Genetics and preventive health care Australian Family Physician 2007 36 10 808 811
3. Soutar A. K., Naoumova R. P., Mechanisms of disease: genetic causes of familial hypercholesterolemia Nature Clinical Practice Cardiovascular Medicine 2007 4 4 214 225 (Pubitemid 46502094)
4. Varret M., Abifadel M., Rabes J. P., Boileau C., Genetic heterogeneity of autosomal dominant hypercholesterolemia Clinical Genetics 2008 73 1 1 13 (Pubitemid 350263516)
5. Leigh S. E., Foster A. H., Whittall R. A., Hubbart C. S., Humphries S. E., Update and analysis of the university college london low density lipoprotein receptor familial hypercholesterolemia database Annals of Human Genetics 2008 2 4 485 498 (Pubitemid 351850090)
6. Baumer J. H., Shield J. P. H., Hypercholesterolaemia in children guidelines review Archives of Disease in Childhood. Education and Practice Edition 2009 94 3 84 86
7. Damgaard D., Larsen M. L., Nissen P. H., Jensen J. M., Jensen H. K., Soerensen V. R., Jensen L. G., Faergeman O., The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population Atherosclerosis 2005 180 1 155 160
8. Neil N. A., Cooper J., Betteridge D. J., Capps N., McDowell I. F.W., Durrington P. N., Seed M., Mann J. I., Humphries S. E., All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: a long-term prospective registry study Atherosclerosis 2010 211 2 618 623
9. Wierzbicki A. S., Humphries S. E., Minhas R., Familial hypercholesterolaemia: summary of nice guidance. Guideline development group British Medical Journal 2008 337, article a1095
10. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 1972 18 6 499 502
11. Kroon A. A., Van't Hof M. A., Demacker P. N. M., Stalenhoef A. F. H., The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels Atherosclerosis 2000 152 2 519 526
12. Scharnagl H., Nauck M., Wieland H., Mrz W., The friedewald formula underestimates LDL cholesterol at low concentrations Clinical Chemistry and Laboratory Medicine 2001 39 5 426 431 (Pubitemid 32529925)
13. Kroon A. A., Aengevaeren W. R., Van Der Werf T., Uijen G. J. H., Reiber J. H. C., Bruschke A. V. G., Stalenhoef A. F. H., LDL-apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis Circulation 1996 93 10 1826 1835 (Pubitemid 26154034)
14. Nishimura S., Sekiguchi M., Kano T., Ishiwata S., Nagasaki F., Nishide T., Okimoto T., Kutsumi Y., Kuwabara Y., Takatsu F., Nishikawa H., Daida H., Yamaguchi H., Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: japan low-density lipoprotein apheresis coronary atherosclerosis prospective study (L-CAPS) Atherosclerosis 1999 144 2 409 417 (Pubitemid 29305475)
15. Mabuchi H., Koizumi J., Shimizu M., Kajinami K., Miyamoto S., Ueda K., Takegoshi T., Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia American Journal of Cardiology 1998 82 12 1489 1495 (Pubitemid 29006472)
16. Kolovou G., Daskalova D., Mastorakou I., Anagnostopoulou K., Cokkinos D. V., Regression of achilles tendon xanthomas evaluated by CT scan after hypolipidemic treatment with simvastatin: a case report Angiology 2004 55 3 335 339 (Pubitemid 38649700)
17. Kolovou G. D., Anagnostopoulou K. K., Pilatis N. D., Iraklianou S., Hoursalas I. S., Liberi S., Pavlidis A. N., Dritsas A., Mikhailidis D. P., Cokkinos D. V., Heterozygote men with familial hypercholesterolaemia may have an abnormal triglyceride response post-prandially. Evidence for another predictor of vascular risk in familial hypercholesterolaemia International Journal of Clinical Practice 2005 59 3 311 317 (Pubitemid 40352748)
18. Kolovou G. D., Dedoussis G. V., Anagnostopoulou K. K., Hatzigeorgiou G. C., Salpea K. D., Choumerianou D. M., Rammos S., Mikhailidis D. P., Cokkinos D. V., Management of a patient with a null low-density lipoprotein receptor mutation: a case report Angiology 2007 57 6 729 732
19. Masaki N., Tatami R., Kumamoto T., Izawa A., Shimada Y., Takamatsu T., Katsushika S., Ishise S., Maruyama Y., Yoshimoto N., Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy International Heart Journal 2005 46 5 833 843
20. Gordon B. R., Kelsey S. F., Dau P. C., Gotto A. M., Graham K., Illingworth D. R., Isaacsohn J., Jones P. H., Leitman S. F., Saal S. D., Stein E. A., Stern T. N., Troendle A., Zwiener R. J., Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system American Journal of Cardiology 1998 81 4 407 411 (Pubitemid 28099529)
21. Keller C., LDL-apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience Atherosclerosis Supplements 2009 10 5 21 26
22. Koziolek M. J., Hennig U., Zapf A., Bramlage C., Grupp C., Armstrong V. W., Strutz F., Mller G. A., Retrospective analysis of long-term lipid apheresis at a single center Therapeutic Apheresis and Dialysis 2009 14 2 143 152
23. Schettler V., Wieland E., Armstrong V. W., Kleinoeder T., Grunewald R. W., Mller G. A., First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management Therapeutic Apheresis 2002 6 5 381 383 (Pubitemid 35203285)
24. Szczepiorkowski Z. M., Winters J. L., Bandarenko N., Kim H. C., Linenberger M. L., Marques M. B., Sarode R., Schwartz J., Weinstein R., Shaz B. H., Guidelines on the use of therapeutic apheresis in clinical practiceevidence-based approach from the apheresis applications committee of the American society for apheresis Journal of Clinical Apheresis 2010 25 3 83 177
25. Thompson G. R., HEART-UK LDL apheresis working group. Recommendations for the use of LDL apheresis Atherosclerosis 2008 198 2 247 255
26. Koga N., Iwata Y., Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia Atherosclerosis 1991 90 1 9 21